The interview below is part of a McGuireWoods series featuring interviews with C-suite leadership of private equity-backed portfolio companies. To recommend a leader for a future interview, email Holly Buckley at hbuckley@mcguirewoods.com or Tim Fry at tfry@mcguirewoods.com.
Q: How do you ensure the platform’s organizational culture is appropriately conveyed to potential targets?
Rich Goode: The
Harvest Partners has announced it has closed its latest fund with $5.34 billion of commitments.
The new fund, Harvest Partners IX, surpassed its target of $5.25 billion.
Harvest, based in New York, is a PE firm investing in middle-market companies generating between $100 million and $3 billion in revenue. Founded in 1981, the firm targets investments
The regulatory landscape for telehealth prescribing of controlled substances is evolving.
In episode 13 of Complications: Health Policy Unraveled, host Stephanie Kennan covers the DEA’s recent extension of pandemic-era telehealth prescribing flexibilities for controlled substances through 2024, marking the second extension. Originally set to expire in May, these extensions followed extensive public input, including 38,000
At McGuireWoods’ 16th annual Healthcare Finance & Growth (HCFG) Conference, a panel of dental industry leaders shared insights with attendees about the market. Panelists included Smiles Ahead COO Sean Barnard, SGA Dental Partners Vice President of M&A Jonathan Mikailonis, Polaris Healthcare Partners Co-founder and Partner Diwakar Sinha, and Edgemont Partners Managing Director Brett Skolnik. The
Hildred Capital Management will acquire Hello Bello, according to a news release.
Hello Bello, founded in 2019 and based in Pacific Palisades, Calif., produces baby and family care products.
Hildred, based in New York, is healthcare-focused private equity firm. Founded in 2018, the firm pursues growth equity investments and seeks to invest
OrbiMed has announced it has raised more than $4.3 billion in commitments for its latest private investment funds.
These new funds include OrbiMed Private Investments IX, OrbiMed Asia Partners V and OrbiMed Royalty & Credit Opportunities IV.
OrbiMed, headquartered in New York, is a life sciences investment firm with more than $17 billion in
COMPLIMENTARY WEBINARTuesday, November 2, 202312-1 p.m. (ET) | 11 a.m.-12 p.m. (CT) | 9-10 a.m. (PT)
Join McGuireWoods partners Kayla McCann Marty and Gretchen Townshend for an informative webinar on the latest developments impacting hospitals, health systems and outpatient facilities. They will explore:
Summit Partners has invested in Hallmark Health Care Solutions, according to a news release.
Hallmark, based in Hauppauge, N.Y., is a healthcare consulting and technology firm. The software-as-a-service (SaaS) company offers physician compensation and workforce management solutions for health systems, academic medical centers and physician groups.
Summit, based in Boston, pursues opportunities
On this episode of The Professor’s Corner, Diwakar Sinha of Polaris Healthcare Partners joins McGuireWoods’ Geoff Cockrell to discuss how practices can prepare to sell, what specialties are most attractive and how the search for investors varies from practice to practice.
According to Diwakar, the same volume of deals is occurring, but the number
The U.S. Department of Health and Human Services (HHS) Office of Research Integrity (ORI) released a notice of proposed rulemaking to update the 2005 Public Health Service (PHS) Policies on Research Misconduct. HHS seeks public comments on the proposal through Dec. 5, 2023.
ORI expects the proposed changes to be effective Jan. 1, 2025. If